Medical cannabis

Medical cannabis is a medicinal product available only by Rpw prescription (for narcotic substances). Its use is regulated by the Act on Counteracting Drug Addiction. In Poland, cannabis is permitted exclusively for medical purposes – not for recreational use.

The import of raw material requires knowledge of specific procedures – and we can support you in this process. We have experience in the import/export of controlled medicines, and all processes are carried out in compliance with the Pharmaceutical Law Act.

Medical cannabis

Applications of medical cannabis

Currently, medical cannabis is used, among others, in the treatment of:

  • chronic pain (e.g. neuropathic),
  • multiple sclerosis,
  • drug-resistant epilepsy,
  • chemotherapy-related symptoms,
  • appetite disorders,
  • insomnia.

Medical cannabis is particularly effective in cases where traditional medicines fail to provide the expected relief.

Medical cannabis

Availability and challenges

Unfortunately, its availability in Poland remains limited.

  • Cultivation requires significant financial resources.
  • Due to its classification (narcotic substance), registration and import processes are subject to strict regulatory procedures.

In this area, we provide full support – we have experience in the import and export of controlled medicines, carrying out all processes in accordance with the Pharmaceutical Law Act.

Market size and growth forecasts

In 2023, the global medical cannabis market was estimated at USD 17–25 billion (depending on the source). According to forecasts, by 2030–2033 the market may reach USD 60–120 billion, with an annual growth rate (CAGR) of around 20–25%.

Sources:

Growth potential in Poland

The Polish market also has significant potential. Its development may accelerate thanks to:

  • simplified regulations,
  • improved drug availability,
  • introduction of reimbursement schemes,
  • development of local production.

Your
trusted
partner

Discover our advantages

Laboratory
Full EU GDP compliance
International reach 
Asset-light model
Regulatory expertise 
Focus on critical medicines
Trusted partners

Pharmaceutical security

We ensure stable supplies and reliable access to therapies in Poland, Central and Eastern Europe, and Central Asia.

Full EU GDP compliance

Certified procedures and quality standards

International reach 

Cooperation with partners from Europe and Asia.

Asset-light model

Flexible and efficient approach without in-house production.

Regulatory expertise 

Competence in registration and transfer of pharmaceutical dossiers.

Focus on critical medicines

We deliver life-saving products.

Trusted partners

We cooperate only with verified manufacturers.

Offer